NeuroClin launches first commercial early detection test for Alzheimer’s

The Glasgow-based firm has partnered with Advance Tests to market the first commercially available, blood biomarker test for the detection of early Alzheimer’s in Scotland.

Glasgow-based NeuroClin has partnered with diagnostic testing…